Glutaminsyre-decarboxylase-antistoffer og diabetes.

Thomas Mandrup-Poulsen

Glutaminsyre-decarboxylase-antistoffer og diabetes.

Translated title of the contribution: Auto-antibodies against glutamic acid decarboxylase and diabetes

Thomas Mandrup-Poulsen

Endocrinology and Metabolism

2 Citations (Scopus)

Abstract

The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes.
Udgivelsesdato: 2007-Jan-22

Translated title of the contribution	Auto-antibodies against glutamic acid decarboxylase and diabetes
Original language	Danish
Journal	Ugeskrift for læger
Volume	169
Issue number	4
Pages (from-to)	300-4
Number of pages	4
ISSN	0041-5782
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{14226150acd211ddb538000ea68e967b,

title = "Glutaminsyre-decarboxylase-antistoffer og diabetes.",

abstract = "The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes. Udgivelsesdato: 2007-Jan-22",

author = "Thomas Mandrup-Poulsen",

note = "Keywords: Autoantibodies; Autoantigens; Decision Making; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity",

year = "2007",

language = "Dansk",

volume = "169",

pages = "300--4",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "4",

}

TY - JOUR

T1 - Glutaminsyre-decarboxylase-antistoffer og diabetes.

AU - Mandrup-Poulsen, Thomas

N1 - Keywords: Autoantibodies; Autoantigens; Decision Making; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity

PY - 2007

Y1 - 2007

N2 - The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes. Udgivelsesdato: 2007-Jan-22

AB - The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes. Udgivelsesdato: 2007-Jan-22

M3 - Tidsskriftartikel

C2 - 17274923

SN - 0041-5782

VL - 169

SP - 300

EP - 304

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 4

ER -